Complex diseases initiative facilitated by SciLifeLab RCP
Genomic Medicine Sweden (GMS) and the Genomic Aggregation Project in Sweden (GAPS) was earlier brought together by the SciLifeLab research community program “Large-scale clinical genomics and complex diseases”. Now, the collaboration has led to yet another focus area within GMS, regarding “complex diseases” – diseases where multiple genes, lifestyle and environmental factors all contribute to the disease.
Allergy, asthma, diabetes, cardiovascular disease and several neurological and psychiatric diseases are all counted as complex diseases and within the GMS Complex diseases initiative a number of those will be selected and tested as a pilot project. The large-scale clinical genomics and complex diseases community will also continue to collaborate to share experiences in the field of complex diseases.
“We are very pleased with our collaboration with GAPS, which now enables us to start up operations in the area of complex diseases,” says Richard Rosenquist Brandell (SciLifeLab/KI), chairman of GMS.
The large-scale clinical genomics and complex diseases community will also continue to collaborate to share experiences in the complex disease field.
Read more on the GMS webpage.
